In addition to the inhibitory effects on atherosclerosis, direct and indirect antiinflammatory actions of GLP-1 medicines on the heart may also contribute to their cardioprotective actions (Figure 3 and Figure 4. This evidence concerns the gene GLP1R and atherosclerosis.